Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 26, 2026, 1:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–34 of 10 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Refractory Schizophrenia Clear all

Conditions: Treatment-resistant Schizophrenia
Interventions: Medtronic Percept with SensSight Deep Brain Stimulation System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 22 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Schizophrenia
Interventions: Clozapine, Olanzapine; Drug
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: 20 Years to 60 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2002
U.S. locations: 1
States / cities: Jamaica Plain, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Minocycline; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Schizophrenia, Auditory Hallucination, Treatment-resistant Schizophrenia
Interventions: stg-rt-fMRI-Neurofeeback, sham-rt-fMRI-Neurofeedback; Other
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 55 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Brockton, Massachusetts

Conditions: Treatment-resistant Schizophrenia
Interventions: Insightec Exablate Neuro MR-guided focused ultrasound transducer; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Schizophrenia, Schizo Affective Disorder
Interventions: Acetazolamide, Placebo; Drug
Lead sponsor: Vishwajit Nimgaonkar, MD PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Schizophrenia
Interventions: Clozapine augmented with atomoxetine up to 40 mg or placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Schizophrenia
Interventions: Lurasidone; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Treatment Resistant Disorders
Interventions: Medtronic Percept with SensSight Deep Brain Stimulation System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 22 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Childhood Onset Psychotic Disorders, Schizophrenia, Psychosis, Mental Disorders
Interventions: Electrical Polarization; Behavioral
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 10 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland